Announcing a new article publication for BIO Integration journal. Bladder cancer (BLCA) is one of the most common malignancies and the second most frequent urogenital tract tumor.

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

EQS-News: Pentixapharm Holding AG / Key word (s): Conference/Scientific publication Pentixapharm to Present First-in-Class Glycan-Dependent CD24 Antibody GT-008 for Solid Tumors at AACR 2025 ...

Conference/Scientific publicationPentixapharm to Present First-in-Class Glycan-Dependent CD24 Antibody GT-008 for Solid Tumors at AACR 2025 25.04.2025 / 15:39 CET/CESTThe issuer is solely responsible ...

A joint research team has developed a modular protein adapter technology that enables the stable attachment of various ...